Cureus | A-Fib Linked to Worse Hospital Outcomes in Multiple Myeloma

A-Fib Linked to Worse Hospital Outcomes in Multiple Myeloma

Jul 21, 2022 | NEWS


A Cureus article was recently highlighted in HealthDay

In stratified analysis, odds of all-cause mortality, hospital stay of more than five days higher for MM patients not using anticoagulation

Overall, 13.1 percent of hospitalized patients with multiple myeloma (MM) have atrial fibrillation, which is associated with worse outcomes, according to a study recently published in Cureus.

Inimfon Jackson, M.D., M.P.H., Ph.D., from Einstein Medical Center in Philadelphia, and colleagues conducted a retrospective cohort analysis using data from the National Inpatient Sample from 2016 to 2018 to explore the prevalence of atrial fibrillation among MM patients and the impact of atrial fibrillation on outcomes.

The researchers found that 13.1 percent of the 68,267 hospitalizations with a diagnosis of MM reported having atrial fibrillation. Compared with those without atrial fibrillation, MM patients with atrial fibrillation had increased odds of inpatient all-cause mortality (adjusted odds ratio, 1.16)...

You can read the full HealthDay article here.